The shares sold earlier this month — on Aug. 5 — were sold at $79.81 per share. This time, Ms. Stryker sold her shares for $80.69 per share with a total transaction valued at more than $1.1 million. She now directly owns 174,605 shares of the company’s stock, valued at $14 million.
In the month of July, Ms. Stryker sold 21,000 shares in two separate transactions, totaling more than $1.7 million. The company’s stock opened at $80.99 per share on Aug. 18 and has a market cap of $30.79 billion.
The company’s second quarter net sales grew 6.8 percent to $2.4 billion, with acquisitions accounting for 2.1 percent of the company’s growth.
More articles on orthopedic devices:
52 spine, orthopedic devices receive FDA 510(k) clearance in July
Smith & Nephew’s new sales model to lower costs: Is it sustainable?
Stryker may have global hip lawsuits settlement soon
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
